Cyclization of a carbon-centered radical derived from oxaziridine cleavage by Usuki, Yoshinosuke et al.
Issue in Honor of Prof. Armand Lattes                                                                       ARKIVOC 2006 (iv) 189-199 
ISSN 1424-6376                                                           Page 189                                                                     ©ARKAT 
Cyclization of a carbon-centered radical derived from  
oxaziridine cleavage 
 
Yoshinosuke Usuki, Xin Peng, Belgin Gülgeze, Shankar Manyem, and Jeffrey Aubé* 
 
Department of Medicinal Chemistry, 1251 Wescoe Hall Drive, Room 4070, Malott Hall, 
University of Kansas, Lawrence, KS 66045-7582, USA 
E-mail: jaube@ku.edu 
 




Treatment of an oxaziridine with low-valent iron or copper salts generates a carbon-centered 
radical able to cyclize onto an appended olefin. 
 






Oxaziridines undergo a wide variety of chemical transformations including rearrangement and 
atom transfer reactions.1 Oxaziridines have long been known to react stoichiometrically with 
low-valent metals such as Fe(II) via single-electron transfer (SET) pathways, affording nitrogen 
radical/oxygen-anion (or hydroxyl if the reaction is run in an acidic medium) pairs that undergo 
different secondary reaction pathways depending on the structure of the oxaziridine.2 Many of 
these products were proposed to result from β-scission of the nitrogen radical to afford a carbon-
centered radical (Scheme 1).2a The existence of R2• has generally been assumed based on the 
isolation of products consistent with traditional radical processes such as hydrogen atom 
abstraction, disproportionation, dimerization,2c and the ability to initiate redox alkene 
polymerization.2b Addition reactions of R2• to electron-poor heterocycles,2e,f NO,2d and an 
Fe(III)-complexed acetylacetate ligand2i have also been cited as evidence for C-radical formation 
in these processes. 
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 The observation of 5-exo-trig cyclizations is considered strong evidence for the 
intermediacy of radicals3 and a powerful synthetic tool besides.4 In this article, we disclose the 
deliberate generation of a carbon-centered radical via oxaziridine SET and β-scission using 
catalytic quantities of a low-valent metal salt under neutral conditions and the cyclization of the 
resulting radical onto an appended olefin. 
 
 
Results and Discussion 
 
We have previously examined the SET reactions of 3-aryl oxaziridines using catalytic amounts 
of a soluble Cu(I) salt in refluxing THF (eq 1).5 Following formation of a putative nitrogen 
radical/oxygen-anion pair, a complex series of steps led to either pyrroline (1, eq 1) or azidirine 
(not shown); both of these products were proposed to result from nitrogen radical addition to the 
olefin followed by migration of the phenyl (N–CH(CH3)Ph) group or rearrangement.5a 
Subsequent attempts to extend this chemistry to oxaziridines bearing a carbomethoxy substituent 
at C-3 failed, leading instead to the isolation of amide (2, eq 1).5b The formation of amide is 
consistent with the preferential β-scission route as shown in Scheme 1 and suggests that the 
formation of pyrroline is contingent on the presence of a C-3 substituent unable to afford a stable 
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 To test this, a series of oxaziridines 3–7 bearing different alkyl substituents at C-3 were 
prepared and subjected to treatment with 5 mol% of [Cu(PPh3)Cl]4 in refluxing THF (eq 1 and 
Table 1).  Throughout this study, oxaziridines were prepared by condensing a ketone with an 
amine in toluene at reflux and treating the crude solution of imine thus made with m-CPBA at –
78 °C.1,5  Except for entries 1, 3, and 4, the oxaziridines in Table 1 were obtained and used as 
mixtures of stereoisomers. The relative amounts of pyrroline 1 vs. amide (usually 2) depended on 
the nature of the C-3 substituent.  In particular, the oxaziridines bearing a radical-stabilizing 
alkyl group at this position furnished the amide exclusively (entries 3–5), whereas when R = Ph, 
none of this product was obtained (entry 1). These data are consistent with a mechanism shown 
in Scheme 1, with only R groups able to afford a reasonably stable radical undergoing β-
cleavage. 
 Oxaziridine 4 derived from a methyl ketone (entry 2) was about midway between these 
extremes; in fact, N-acetyl-α-methylbenzylamine 9, and not amide 2, was the β-scission product 
observed in this case because loss of the 3-butenyl radical should be favored relative to Me•. The 
pyrroline 8 and amide 9 obtained in this case could not be separated and, hence, 8 was isolated as 
the pivaloyl amide 10 after treating the reaction mixture with pivaloyl chloride. The observed 
variations in ratios of 1 and 2 could not be explained based solely on the relative rates of β-
fragmentation for the R groups (collected in Table 1). Additionally, no definitive information 
regarding the nature of the departing group or its fate could be inferred from these experiments 
(no attempt was made to isolate the non-amide products of these reactions). 
 











1, R = Ph
8, R = Me

















Isolated yield (%) 
Entry R Compound krela,6 Cyclization product Cleavage product 
1 Ph- 3 23 66 (1) - 
2 CH3- 4 1 21 (10) 44 (9) 
3 3-butenyl 5 100b - 76 (2) 
4 (CH3)2CH- 6 3,600 - 89 (2) 
5 PhCH2- 7 11,900 - 57 (2)c 
(a) Relative rates of fragmentation (s-1) of RC(CH3)2O• radicals at 40 °C. (b) Data for CH3CH2• 
used. (c) Based on 28% recovered oxaziridine. 
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 We considered the possibility of generating radicals that could be utilized in further radical 
processes. Accordingly, oxaziridine 12 (see Scheme 2 for structures) was synthesized in the 
expectation that it would undergo β-scission efficiently due to the production of a benzylic 
radical in so doing.  An achiral amine was used to minimize complications in product analysis 
resulting from stereoisomer formation.  Indeed, treatment with a variety of Cu(I) and Fe(II) salts 
in refluxing THF led smoothly to the formation of products 13a, 13b, and 14 resulting from 
cyclization of the carbon-centered radical. As seen in Table 2, all of the soluble catalysts used 
gave comparable results in terms of yield and product ratio.  
 
Table 2.  Results of cyclization experiments using 12. 
Entry Catalyst Combined yield (%) 13a : 13b : 14a 
1 [Fe(bpy)3](PF6)2 71 21 : 68 : 11 
2 FeBr2 60 18 : 68 : 14 
3 [Cu(bpy)(PPh3)]Cl 67 21 : 73 : 6 
4 [Cu(CH3CN)4]PF6 76 20 : 70 : 10 
5 [Cu(PPh3)Cl]4 66 19 : 72 : 9 
aDetermined by 500 MHz 1H-NMR integration. 
 
 Our proposed mechanism is depicted in Scheme 2. Cyclopentanes 13a and 13b result from 
addition of the benzylic radical to the olefin in a 5-exo-trig manner followed by hydrogen atom 
abstraction from a molecule of THF.7 In the similar cyclization of 1-phenylhexen-5-yl radical 
investigated by Walling, the trans-cyclopentane 13b was obtained as the only product.8 In our 
case, 13b was the major product in accord with the Beckwith-Houk model.9 The decreased 
diastereoselectivity may be related to the changes in solvent polarity or the possibility that the 
cyclization is occurring inside the solvent cage. The production of 14 is attributed to the 
oxidative addition of the initially formed methylene radical into the phenyl group; such additions 
are commonly observed10 and appeared in the mechanism originally proposed for the formation 
of 1.5 It seems reasonable that Cu(I) is regenerated via SET from the amide anion to the Cu(II) 
formed in the first step (shown in Scheme 2 as an ion pair for book-keeping purposes). 
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 Two aspects of these reactions are noteworthy. First, the observation of cyclization 
products from 12 constitutes good evidence that the initially formed nitrogen-centered radical 
actually undergoes β-scission to eject a carbon-centered radical. Second, the use of catalytic 
amounts of soluble Fe(II) and Cu(I) salts for initiating oxaziridine SET under neutral conditions 
is quite mild and synthetically attractive relative to the original techniques used for such 
reactions.2 Although further studies will be necessary to establish the generality of this process, 
the recognition that oxaziridines are readily accessible from the corresponding ketones suggests 
that the overall sequence of 11 → 12 → radical may constitute an interesting approach to a 
decarbonylative method for carbon radical generation under mild, catalytic conditions. 
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Experimental Section 
 
General Procedures. THF was freshly distilled from sodium–benzophenone and degassed by 
multiple freeze-thaw cycles at <0.5 mm Hg. 1H and 13C NMR spectra were recorded on a 500 
MHz NMR spectrometer (at 500 and 125.5 MHz, respectively) or on a 300 MHz machine (at 300 
and 75.6 MHz, respectively). All NMR samples were dissolved in deuteriochloroform, and 
chemical shifts are given in parts per million (ppm) relative to the internal standard 
tetramethylsilane (TMS). Optical rotations were measured on a Perkin-Elmer 241 polarimeter, 
and concentrations are reported in g/100 mL. Elemental analyses were obtained in-house. Unless 
otherwise noted, starting materials were obtained from commercial suppliers and used without 
further purification. [Cu(CH3CN)4]PF6,11 [Cu(bpy)(PPh3)]Cl,12 and [Cu(PPh3)Cl]413 were 
prepared according to literature procedures.  
General procedure for preparation of oxaziridines. To a solution of the starting ketone (1.0 
equiv) in toluene was added 1.2–2.0 equiv of α-methylbenzylamine (αMBA), freshly crushed 
5Å molecular sieves, and 5 mol% of p-toluenesulfonic acid monohydrate.  The reaction mixture 
was then refluxed in a three-necked round-bottom flask equipped with a water-cooled condenser 
and drying tube for ca. 48 h.  While the imine solution was cooling, a flame-dried round bottom 
flask kept under N2 atmosphere was charged with m-CPBA (1.2–2.0 equiv) and methylene 
chloride to completely dissolve the m-CPBA.  The flask was cooled to –78 °C and the imine 
solution was then transferred to the m-CPBA solution via a wide-bore cannula.  The reaction was 
followed by TLC and was generally complete within one hour, at which time, it was quenched 
with saturated Na2S2O3 and allowed to warm to room temperature.  The layers were separated, 
and the organic layer was washed with saturated NaHCO3, brine, and dried over Na2SO4. 
Concentration followed by column chromatography or medium-pressure liquid chromatography 
(MPLC) on silica gel with the indicated solvent system provided the oxaziridine. 
General procedure for Cu(I) or Fe(II) promoted cyclization (Table 2, Entry 4). The 
substrate concentration was fixed at 0.05 M, and 5 mol% of catalyst was used in all cases. The 
following procedure is representative. A mixture of [Cu(CH3CN)4]PF611 (12 mg, 0.032 mmol, 
0.05 equiv) and degassed THF (110 mL) in a Schlenk-type reaction vessel was refluxed for 30 
min under Ar atmosphere. To the resulting solution was transferred dropwise a solution of 2-
diphenylmethyl-3-phenyl-3-(1'-phenyl-5'-hexen-1'-yl)oxaziridine 12 (246 mg, 0.642 mmol) in 
degassed THF (15 mL plus 5 mL rinse) via a cannula over a 5 min period. Refluxing was 
continued for an additional 20 h. After cooling to room temperature, the solvent was carefully 
evaporated. Column chromatography of the residue using pentane afforded 78 mg (76%) of a 
colorless oil whose composition was assigned as a 20:70:10 mixture of cis and trans-1-phenyl-2-
methylcyclopentane 13a,b and 1,2,3,3a,8,8a-hexahydrocyclopent[a]indene 14 by 1H-NMR 
integration. This mixture was chromatographically (TLC) inseparable, and the products thus 
obtained were identical in all respects with the authentic samples prepared as reported below. 
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Compound characterization 
 
Compounds 1 and 3 have been previously described.5 
N-(S)-α-methylbenzyl-3-pentenylamide (2). According to the general procedure, 
[Cu(PPh3)Cl]4 (0.05 equiv) in dry THF was reacted with oxaziridine 5 (1 equiv).  The reaction 
mixture was refluxed for 7 h.  Column chromatography with 1:3 ethyl acetate/hexane afforded 
the title compound as light yellow oil.  Rf  0.22 (1:3 ethyl acetate/hexane); 1H NMR (300 MHz, 
CDCl3) δ 1.46 (d, J = 6.9 Hz, 3H), 2.24 (m, 2H), 2.37 (m, 2H), 4.97 (q, J = 6.9 Hz, 1H), 5.05 (m, 
2H), 5.80 (m, 1H), 5.99 (br. s, 1H), 7.28 (m, 5H); 13C NMR (74.5 MHz, CDCl3) δ 21.8, 29.7, 
35.9, 48.7, 115.6, 126.2, 127.3, 128.6, 137.1, 143.3, 171.4; IR (CCl4) 3420, 3295, 3030, 3015, 
2968, 2925, 1740, 1640, 1540, 1492, 1450, 1372, 1240 cm–1; MS (CI) m/e 221 (M++NH4+), 204 
(M++1); Anal. calcd for C13H17NO: C, 76.81; H, 8.43; N, 6.89; found: C, 76.60; H, 8.40; N, 6.70. 
Racemic-3-(3'-butenyl)-3-methyl-2-(1'-phenylethyl)oxaziridine (4).  According to the general 
procedure, commercially available 5-hexen-2-one (10.0 g, 0.11 mol) was reacted with racemic 
α-MBA (16.0 g, 0.15 mol) followed by oxidation with m-CPBA (30 g, 0.13 mol). Column 
chromatography with 3:97 ethyl acetate/hexane afforded the title compound as a mixture of two 
diastereomers.  Fractional distillation gave 4a (3.41 g, 14% yield). Rf 0.48 (10% ethyl 
acetate/hexane); 1H NMR (300 MHz, CDCl3) δ 1.42 (s, 3H), 1.48 (d, J = 6.6 Hz, 3H), 1.81–2.32 
(m, 4H), 3.03 (q, J = 6.6 Hz, 1H), 4.85 (m, 2H), 5.68 (m, 1H), 7.35 (m, 5H); 13C NMR (74.5 
MHz, CDCl3) δ 16.0, 23.1, 28.5, 38.6, 62.6, 84.0, 114.7, 127.1, 127.6, 128.6, 137.6, 141.2; MS 
(CI) m/e 218 (M++1), 120, 111, 105; Anal. calcd for C14H19NO: C, 77.38; H, 8.81; N, 6.44; 
found: C, 77.69; H, 9.01; N, 6.30. For compound 4b (4.15 g, 17% yield): Rf 0.48 (10% ethyl 
acetate/hexane); 1H NMR (300 MHz, CDCl3) δ 1.41 (s, 3H), 1.58 (d, J = 6.4 Hz, 3H), 1.73 (m, 
1H), 1.90 (m, 2H), 2.05 (m, 1H), 3.66 (q, J = 6.4 Hz, 1H), 4.97 (m, 2H), 5.72 (m, 1H), 7.37 (m, 
5H); 13C NMR (74.5 MHz, CDCl3) δ 23.5, 23.6, 29.6, 30.5, 62.0, 84.3, 115.2, 126.8, 127.6, 
128.7, 137.2, 141.6. 
(2R, αS)-3,3-Di(3'-butenyl)-2-(1'-phenylethyl)oxaziridine (5). According to the general 
procedure, 1,8-nonadien-5-one14 (0.200 g, 1.45 mmol) was reacted with (S)-α-MBA (0.350 g, 
2.90 mmol) followed by oxidation with m-CPBA (0.500 g, 2.90 mmol). Column chromatography 
with 3:97 ethyl acetate/hexane afforded the title compound as a light yellow oil (0.269 g, 72% 
yield). Rf  0.58 (10% ethyl acetate/hexane); 1H NMR (300 MHz, CDCl3) δ 1.56 (d, J = 6.6 Hz, 
3H), 1.77–2.40 (m, 8H), 3.66 (q, J = 6.4 Hz, 1H), 4.88 (m, 4H), 5.72 (m, 2H), 7.35 (m, 5H); 13C 
NMR (74.5 MHz, CDCl3) δ 23.8, 28.6, 28.8, 29.9, 35.8, 62.3, 86.3, 115.1, 127.4, 128.1, 128.9, 
129.1, 137.6, 138.1, 141.7; IR (CCl4) 3035, 2965, 2920, 1635, 1445, 980 cm–1; MS (EI) m/e 258 
(M++1), 240, 202, 186, 166, 136, 125, 105, 77, 55; HRMS calcd for C17H23NO: M+ = 257.1778; 
found: M+ = 257.1783.  
(2R, 3R, αS)-3-(3'-Butenyl)-3-isopropyl-2-(1'-phenylethyl)oxaziridine (6). According to the 
general procedure, 2-methyl-6-hepten-3-one15 (0.400 g, 3.17 mmol) was reacted with (S)-α-
MBA (0.600 g, 5.00 mmol) followed by oxidation with m-CPBA (0.706 g, 3.80 mmol, 1.2 
equiv).  Column chromatography with 3:97 ethyl acetate:hexane afforded the title compound as a 
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light yellow oil (0.205 g, 27% yield). Rf 0.54 (10% ethyl acetate/hexane); 1H NMR (300 MHz, 
CDCl3) δ 0.80 (d, J = 5.4 Hz, 3H), 0.83 (d, J = 7.0 Hz, 3H), 1.55 (d, J = 6.3 Hz, 3H), 1.76–1.81 
(m, 3H), 2.07 (m, 1H), 2.15 (m, 1H), 3.57 (q, J = 6.4 Hz, 1H), 4.96–5.05 (m, 2H), 5.75–5.84 (m, 
1H), 7.25–7.37 (m, 5H); 13C NMR (125.5 MHz, CDCl3) δ 16.6, 17.3, 23.5, 26.3, 30.1, 33.7, 61.9, 
88.2, 114.9, 127.0, 127.5, 128.5, 137.5, 141.5; IR (CCl4) 2945, 2925, 1585, 1420, 1365, 1235, 
1130, 1005 cm–1; MS (EI) m/e 245 M+, 228, 214, 202, 186, 172, 162, 138, 120, 104, 77; [α]D –
18.1 (c=0.5, methanol); Anal. calcd for C16H23NO: C, 78.32; H, 9.45; N, 5.71; found: C, 78.70; 
H, 9.80; N, 6.10. 
(2R, 3S, αS)-3-Benzyl-(3'-butenyl)-2-(1'-phenylethyl)oxaziridine (7a) and (2R, 3R, αS)-3-
Benzyl-(3'-butenyl)-2-(1-phenylethyl)oxaziridine (7b).  According to the general procedure, 1-
phenyl-5-hexen-2-one16 (0.3 g, 1.72 mmol) was reacted with (S)-α-MBA (0.313 g, 2.58 mmol 
1.5 equiv) followed by the oxidation with m-CPBA (0.550 g, 2.72 mmol). Column 
chromatography with 1:1 benzene:hexane afforded the title compound (a mixture of two 
diastereomers) as an oil.  Further chromatography with 2:98 ethyl acetate:hexane allowed for the 
partial separation of the two major diastereomers.  For diastereomer 7a (0.120 g, 24% yield): Rf 
0.51 (50% benzene/hexane); 1H NMR (300 MHz, CDCl3) δ 1.25 (m, 2H), 1.56 (d, J = 6.4 Hz, 
3H), 1.75 (m, 1H), 1.90 (m, 1H), 2.98 (dd, J = 7.9, 6.9 Hz, 2H), 3.79 (q, J = 6.4 Hz, 1H), 4.72 
(m, 2H), 5.51 (m, 1H), 7.06–7.42 (m, 10H); 13C NMR (75.4 MHz, CDCl3) δ 23.4, 28.3, 34.9, 
35.6, 62.6, 114.6, 126.8, 127.3, 127.8, 128.6, 128.8, 129.6, 136.3, 137.7, 140.9; IR (CCl4) 3060, 
3020, 2965, 2920, 1645, 1490, 1448, 920, 700 cm–1; MS (CI) m/e 294 (M++1), 278, 226, 175, 
120; [α]D –41.6 (c=1.1, methanol); Anal. calcd for C20H23NO: C, 81.87; H, 7.91; N, 4.77; found: 
C, 81.99; H, 8.30; N, 5.17. Diastereomer 7b (0.139 g, 28% yield): Rf 0.56 (50% 
benzene/hexane); 1H NMR (300 MHz, CDCl3) δ 1.65 (d, J = 6.0 Hz, 3H), 1.80–2.02 (m, 3H), 
2.20 (m, 1H), 2.95 (dd, J = 6.9 Hz, 2H), 3.75 (q, J = 6.3 Hz, 1H), 4.95 (m, 2H), 5.70 (m, 1H), 
7.20–7.40 (m, 10H); 13C NMR (74.5 MHz, CDCl3) δ 23.0, 27.4, 29.5, 43.3, 62.0, 87.0, 115.3, 
126.6, 127.4, 127.8, 128.3, 128.6, 129.5, 135.8, 137.1, 140.7; IR (CCl4) 3060, 3020, 2985, 2920, 
1635, 1500, 1490, 1450, 910, 695 cm–1; MS (CI) m/e  294 (M++1), 204, 120; [α]D –43.2 (c=1.2, 
methanol); Anal. calcd for C20H23NO: C, 81.87; H, 7.91; N, 4.77; found: C, 82.02; H, 8.18; N, 
5.00. 
2-Oxo-6-phenyl-hexan-5-amine, tert-butyl amide (10). Following the general procedure, 
oxaziridine 4 (0.500 g, 2.30 mmol) was reacted with [Cu(PPh3)Cl]4 (0.041 g, 0.05 equiv).  The 
reaction mixture was refluxed for 5 h, and concentrated.  The crude mixture was dissolved in dry 
pyridine (4 ml), and pivaloyl chloride (0.71 ml, 5.76 mmol) was added.  The resulting mixture 
was stirred at room temperature overnight, and diluted with methylene chloride.  The organic 
phase was washed with 2M HCl solution, saturated aqueous NaHCO3, brine, and dried over 
Na2SO4.  The solution was concentrated and purified by flash column chromatography eluting 
with 250:20:1 methylene chloride:methanol:ammonium hydroxide to afford the title compound 
as a yellow solid (0.14 g, 21% yield): mp 81–82 °C; Rf 0.5 (250:20:1 CH2Cl2:MeOH:NH4OH); 
1H NMR (300 MHz, CDCl3) δ 1.08 (s, 9H), 1.73 (m, 2H), 2.11 (s, 3H), 2.48 (m, 2H), 2.78 (m, 
2H), 4.05 (m, 1H), 5.59 (br d, 1H), 7.23 (m, 5H); 13C NMR (125.7 MHz, CDCl3) 27.4, 30.1, 
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38.6, 40.6, 41.6, 50.3, 126.5, 128.4, 129.4, 137.8, 178.2, 209.1; IR (CCl4) 3440, 1710, 1655 cm–
1; MS (CI) m/e 276 (M++1), 184, 174, 100, 91, 82, 57.  Anal. calcd for C17H27NO2: C, 74.14: H, 
9.15; N, 5.08; found; C, 74.00; H, 9.00; N, 4.81. An additional 44% of 917 was also isolated. 
3-Phenyl-7-octen-2-one (11).  A mixture of 3-phenyl-7-octen-2-one dimethylhydrazone18 (1.566 
g, 6.41 mmol) and iodomethane (2.0 mL, 32.1 mmol) was stirred for 48 h at rt. An excess of 
iodomethane was removed under reduced pressure to afford crude 3-phenyl-7-octen-2-one 
trimethylhydrazonium iodide quantitatively, which was treated with pentane (20 mL) and 6M 
HCl (10 mL). Vigorous stirring was continued for 3 h at rt. The aqueous layer was extracted with 
pentane (2 × 20 mL). The combined organic phases were washed with brine (30 mL) and dried 
over Na2SO4. Flash column chromatography (5% EtOAc/hexane) afforded the title compound as 
a clear oil (1.07 g, 83%):  1H NMR (300 MHz, CDCl3) δ 1.21–1.37 (m, 2H), 1.64–1.77 (m, 2H), 
1.98–2.17 (m, 2H), 2.05 (s, 3H), 3.60 (t, J = 7.4 Hz, 1H), 4.90–5.01 (m, 2H), 5.68–5.81 (m, 1H), 
7.14–7.36 (m, 5H); 13C NMR (75.4 MHz, CDCl3) δ 26.6, 28.9, 31.1, 33.5, 59.5, 114.6, 127.1, 
128.1, 128.8, 138.3, 138.9, 208.2; IR (CCl4) 1715 cm–1; MS (EI) m/e 202 (M+), 91 (100); HRMS 
(FAB) calcd for C14H19O(M+H): 203.1436, found 203.1446. 
2-Diphenylmethyl-3-methyl-3-(1'-phenyl-5'-hexen-1'-yl)oxaziridine (12). According to the 
general procedure, 3-phenyl-7-octen-2-one (168 mg, 0.831 mmol) was reacted with 
diphenylmethylamine (229 mg, 1.25 mmol) in toluene (7 mL) followed by oxidation with m-
CPBA (216 mg, 1.25 mmol). Flash column chromatography (3–5% EtOAc/hexane) afforded the 
title compound (226 mg, 71%) as a pale yellow oil, which was a chromatographically (TLC) 
inseparable mixture of diastereomers in a 2:1 ratio (from 1H NMR): 1H NMR (300 MHz, CDCl3) 
δ 1.14–1.34 (m, 2H), 1.40 (s, 3H), 1.57–2.04 (m, 4H), 4.63 (m, 0.66H), 4.70 (s, 0.34H), 4.88–
4.98 (m, 2H), 5.60–5.79 (m, 1H), 7.04–7.54 (m, 15H); 13C NMR (75.4 MHz, CDCl3) (for major 
isomer) δ 13.5, 26.7, 28.5, 33.7, 53.9, 70.3, 86.8, 114.5, 126.7, 127.1, 127.4, 127.7, 128.1, 128.3, 
128.4, 128.6, 128.7, 138.5, 139.4, 139.8, 142.1;  IR (neat) 2920, 1490 cm–1; MS (EI) m/e  384 
(M++1), 167 (100); HRMS (FAB) calcd for C27H30NO (M+H) 384.2327, found 384.2347. Anal. 
calcd for C27H29NO: C, 84.56; H, 7.62; N, 3.65. Found: C, 84.20; H, 7.58; N, 3.28. 
1-Phenyl-2-methylcyclopentane (13a,b). To a round-bottom flask containing a mixture of Li 
(199 mg, 28.7 mmol), NH3 (36 mL) and THF (18 mL) was added a solution of 1-phenyl-2-
methylcyclopentanol19 (1.585 g, 8.99 mmol) in THF (18 mL) over 10 min at -78 °C under Ar 
atmosphere. After stirring for 10 min, solid NH4Cl (ca. 2.2 g) was cautiously added to discharge 
the blue color over a few minutes. NH3 was allowed to evaporate overnight. The residue was 
partitioned between brine and Et2O (each 50 mL). The organic phase was dried over Na2SO4. 
Flash column chromatography (10% EtOAc/hexane) yielded the unreacted alcohol (577 mg, 
36%) and a mixture of cis and trans isomers20 (651 mg, 45% yield): 1H NMR (300 MHz, CDCl3) 
δ 0.57 (d, J = 7.1 Hz, 3H), 0.91 (d, J = 6.3 Hz, 3H), 1.26–2.45 (m, 10H), 3.14 (q, 6H), 7.16–7.31 
(m, 10H); 13C NMR (75.4 MHz, CDCl3) δ 16.2, 18.6, 23.3, 23.9, 29.0, 33.4, 34.8, 35.4, 38.2, 
43.0, 49.2, 54.5, 125.5, 125.8, 127.5, 127.8, 128.2, 128.4, 143.5, 145.4; IR (neat) 2940, 1445 cm–
1; MS (EI) m/e  160 (M+), 104 (100). 
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1,2,3,3a,8,8a-Hexahydrocyclopent[a]indene (14). This compound was prepared according to a 
literature procedure21 using 2-phenyl-1-cyclopentane carboxylic acid22 as a starting material  in 
57% yield (two steps): 1H NMR (500 MHz, CDCl3) δ 1.33–2.09 (m, 6H), 2.67 (dd, J = 2.9, 16.5 
Hz, 1H), 2.86 (m, 1H), 3.21 (dd, J = 8.9, 16.5 Hz, 1H),  3.63 (dt, J = 2.9, 8.6 Hz, 1H), 7.15 (s, 
4H); 13C NMR (75.4 MHz, CDCl3) δ 26.1, 34.1, 34.9, 41.7, 50.3, 124.37, 124.44, 126.1, 126.4, 
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